Progress in gynecologic cancer research: the Gynecologic Oncology Group experience
about
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study.Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.Factors affecting risk of mortality in women with vaginal cancer.New pharmacotherapy options for cervical cancer.
P2860
Progress in gynecologic cancer research: the Gynecologic Oncology Group experience
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Progress in gynecologic cancer research: the Gynecologic Oncology Group experience
@en
type
label
Progress in gynecologic cancer research: the Gynecologic Oncology Group experience
@en
prefLabel
Progress in gynecologic cancer research: the Gynecologic Oncology Group experience
@en
P2860
P1433
P1476
Progress in gynecologic cancer research: the Gynecologic Oncology Group experience
@en
P2093
George A Omura
Gynecologic Oncology Group
P2860
P304
P356
10.1053/J.SEMINONCOL.2008.07.007
P577
2008-10-01T00:00:00Z